lobbying_activities: 838113
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 838113 | 80cc479f-de05-426d-be75-841f730f4747 | Q3 | GILBERT'S LLP | 67876 | MYLAN LABORATORIES INC | 2009 | third_quarter | PHA | Reform to legislation and regulations affecting pharmaceutical drug approval and marketing | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2009-10-19T14:19:01-04:00 |